Hepatorenal Syndrome Global Clinical Trials Review, H1, 2015

Hepatorenal Syndrome Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2659CTIDB
  • |
  • Pages: 83
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Hepatorenal Syndrome Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Hepatorenal Syndrome Global Clinical Trials Review, H1, 2015" provides data on the Hepatorenal Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatorenal Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatorenal Syndrome. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Hepatorenal Syndrome 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Clinical Trials by G7 Countries: Proportion of Hepatorenal Syndrome to Gastrointestinal Clinical Trials 14

Clinical Trials by Phase in G7 Countries 15

Clinical Trials in G7 Countries by Trial Status 16

Clinical Trials by E7 Countries: Proportion of Hepatorenal Syndrome to Gastrointestinal Clinical Trials 17

Clinical Trials in E7 Countries by Trial Status 18

Clinical Trials by Phase 19

In Progress Trials by Phase 20

Clinical Trials by Trial Status 21

Clinical Trials by End Point Status 22

Unaccomplished Trials of Hepatorenal Syndrome 23

Subjects Recruited Over a Period of Time 25

Clinical Trials by Sponsor Type 26

Prominent Sponsors 27

Top Companies Participating in Hepatorenal Syndrome Therapeutics Clinical Trials 28

Prominent Drugs 29

Clinical Trial Profiles 30

Clinical Trial Overview of Top Companies 30

La Jolla Pharmaceutical Company 30

Clinical Trial Overview of La Jolla Pharmaceutical Company 30

Ferring International Center S.A. 31

Clinical Trial Overview of Ferring International Center S.A. 31

Orphan Therapeutics, LLC 32

Clinical Trial Overview of Orphan Therapeutics, LLC 32

Novartis AG 33

Clinical Trial Overview of Novartis AG 33

Noorik Biopharmaceuticals AG 34

Clinical Trial Overview of Noorik Biopharmaceuticals AG 34

Max India Limited 35

Clinical Trial Overview of Max India Limited 35

Ikaria Holdings, Inc. 36

Clinical Trial Overview of Ikaria Holdings, Inc. 36

Curatis Pharma GmbH 37

Clinical Trial Overview of Curatis Pharma GmbH 37

Cumberland Pharmaceuticals, Inc. 38

Clinical Trial Overview of Cumberland Pharmaceuticals, Inc. 38

Clinical Trial Overview of Top Institutes / Government 39

Hospital Clinic de Barcelona 39

Clinical Trial Overview of Hospital Clinic de Barcelona 39

University of Virginia 40

Clinical Trial Overview of University of Virginia 40

All India Institute of Medical Sciences 41

Clinical Trial Overview of All India Institute of Medical Sciences 41

Austin Health 42

Clinical Trial Overview of Austin Health 42

Azienda Ospedaliera di Padova 43

Clinical Trial Overview of Azienda Ospedaliera di Padova 43

Charite-Universitatsmedizin Berlin 44

Clinical Trial Overview of Charite-Universitatsmedizin Berlin 44

Fundacio Clinic per a la Recerca Biomedica 45

Clinical Trial Overview of Fundacio Clinic per a la Recerca Biomedica 45

Isfahan University of Medical Sciences 46

Clinical Trial Overview of Isfahan University of Medical Sciences 46

Pomeranian Medical University 47

Clinical Trial Overview of Pomeranian Medical University 47

Postgraduate Institute of Medical Education and Research 48

Clinical Trial Overview of Postgraduate Institute of Medical Education and Research 48

Five Key Clinical Profiles 49

Appendix 81

Abbreviations 81

Definitions 81

Research Methodology 82

Secondary Research 82

About GlobalData 83

Contact Us 83

Disclaimer 83

Source 83

List of Figures

Hepatorenal Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Hepatorenal Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Hepatorenal Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Hepatorenal Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10

Hepatorenal Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Hepatorenal Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Proportion of Hepatorenal Syndrome to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 14

Hepatorenal Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15

Hepatorenal Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16

Proportion of Hepatorenal Syndrome to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 17

Hepatorenal Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 18

Hepatorenal Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2015* 19

Hepatorenal Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 20

Hepatorenal Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21

Hepatorenal Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2015* 22

Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25

Hepatorenal Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 26

Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27

Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28

Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29

GlobalData Methodology 82

List of Tables

Hepatorenal Syndrome Therapeutics, Global, Clinical Trials by Region, 2015* 7

Hepatorenal Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Hepatorenal Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Hepatorenal Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10

Hepatorenal Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Hepatorenal Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Hepatorenal Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Proportion of Hepatorenal Syndrome to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 14

Hepatorenal Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15

Hepatorenal Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16

Proportion of Hepatorenal Syndrome to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 17

Hepatorenal Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 18

Hepatorenal Syndrome Therapeutics, Global, Clinical Trials by Phase, 2015* 19

Hepatorenal Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 20

Hepatorenal Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21

Hepatorenal Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2015* 22

Hepatorenal Syndrome Therapeutics, Global, Suspended Clinical Trials, 2015* 23

Hepatorenal Syndrome Therapeutics, Global, Terminated Clinical Trials, 2015* 24

Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25

Hepatorenal Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 26

Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27

Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28

Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29

Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by La Jolla Pharmaceutical Company, 2015* 30

Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring International Center S.A., 2015* 31

Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Orphan Therapeutics, LLC, 2015* 32

Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 33

Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Noorik Biopharmaceuticals AG, 2015* 34

Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Max India Limited, 2015* 35

Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Ikaria Holdings, Inc., 2015* 36

Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Curatis Pharma GmbH, 2015* 37

Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Cumberland Pharmaceuticals, Inc., 2015* 38

Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Clinic de Barcelona, 2015* 39

Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia, 2015* 40

Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2015* 41

Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Austin Health, 2015* 42

Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera di Padova, 2015* 43

Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite-Universitatsmedizin Berlin, 2015* 44

Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Fundacio Clinic per a la Recerca Biomedica, 2015* 45

Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2015* 46

Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Pomeranian Medical University, 2015* 47

Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Postgraduate Institute of Medical Education and Research, 2015* 48

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Hepatorenal Syndrome Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Hepatorenal Syndrome, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

select a license

Single User License
USD 2500 INR 160650
Site License
USD 5000 INR 321300
Corporate User License
USD 7500 INR 481950

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com